- Gene therapy for blistering skin disease appears to enhance healing in clinical trial
- Stanford’s lab for cell, gene medicine opens in Palo Alto
- Stanford announces new Center for Definitive and Curative Medicine
- Gene Transfer Study for RDEB
- Characteristics of Dystrophic Epidermolysis Bullosa
- Epidermolysis Bullosa Clinical Research Consortium (EBCRC) Study
- NK-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa (EB) Patients
- A Phase 3 Study of SD-101 Cream in Patients with Epidermolysis Bullosa
- Autologous Fibroblast Study for RDEB
The Butterfly Effect
Alfred T. Lane, MD, discusses EB research and treatment
Support EB Research
Your support will help us accomplish our goal to ease the suffering of EB patients much sooner. To make a donation now, please click on the button above.
If you wish to mail a donation, the addresses are listed below. Please make checks payable to “Stanford University” with a note designating your gift to the area of your choice.
Please make checks payable to “Stanford University” with a note designating your gift to the area of your choice.
P.O. Box 20466
Stanford, CA 94309
For More Information, Please Contact Development:
Kat Walsch, Senior Associate Director of Major Gifts
Medical Center Development
Phone: 650.724.9860 or Cell: 650.785.4511